Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer modelYoriko Yamashita‐Kashima, Kaori Fujimoto-OuchiOncology ReportsJune 19, 201310.3892/or.2013.2547Cited by 46SaveCiteExport RISWatch citationsRelated PapersBiomarkers for antitumor activity of bevacizumab in gastric cancer models|BMC Cancer|2012|32Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft model|Oncology Letters|2017|25